Track market-moving stories before they get noisy

Shares of Aduro Clean Technologies Inc. (ADUR - Free Report) have gained 30.6% over the past four weeks to close the last trading session at $13.5, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $29 indicates a potential upside of 114.8%.

The mean estimate comprises three short-term price targets with a standard deviation of $14.8. While the lowest estimate of $19.00 indicates a 40.7% increase from the current price level, the most optimistic analyst expects the stock to surge 240.7% to reach $46.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice.

However, an impressive consensus price target is not the only factor that indicates a potential upside in ADUR. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You May Not Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.

Why ADUR Could Witness a Solid UpsideAnalysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason to expect an upside in the stock. That's because empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Over the last 30 days, the Zacks Consensus Estimate for the current year has increased 13.2%, as one estimate has moved higher compared to no negative revision.

Moreover, ADUR currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Therefore, while the consensus price target may not be a reliable indicator of how much ADUR could gain, the direction of price movement it implies does appear to be a good guide.

LONDON, Ontario, May 19, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announces that it has received conditional approval to list its common shares on the Toronto Stock Exchange (“TSX”) under the symbol “ACT”. Final approval of the listing remains subject to the Company fulfilling all the requirements of the TSX, including receipt of all required documentation.

The Company will issue a news release once the TSX confirms the expected trading date. In connection with the TSX listing, the Company expects to delist its common shares from the Canadian Securities Exchange (“CSE”). Shareholders are not required to exchange their share certificates or take any other action in connection with the listing, as there will be no change in the trading symbol or CUSIP for the common shares.

“Since going public on the CSE in 2021, Aduro has advanced from an early-stage public technology company into a Nasdaq-listed chemical technology developer with a strengthened balance sheet and expanding industrial commercialization programs,” said Ofer Vicus, Chief Executive Officer of Aduro. “The Company has progressed its Hydrochemolytic™ Technology (“HCT”) through Next Generation Process (“NGP”) Pilot Plant operating campaigns, First-of-a-Kind (“FOAK”) industrial project development, commercial offtake engagement, license package development, and expanded petroleum applications. We sincerely thank the CSE for providing a platform for our early public-market growth and investor access and look forward to taking this next step with the Toronto Stock Exchange as we continue advancing HCT across waste plastics, heavy hydrocarbons, and renewable oils.”

Aduro is currently included in the CSE25 Index, which represents the 25 largest companies on the Canadian Securities Exchange by market capitalization. This is a testament to Aduro’s growing capital markets profile and shareholder recognition for the continued progress achieved since Aduro’s public listing on the CSE. The proposed TSX listing represents the next stage in Aduro’s capital markets evolution, supporting broader market visibility, increased access to institutional investors, and the continued development of the Company’s Canadian public-market profile.

About Aduro Clean Technologies

Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company’s Hydrochemolytic™ Technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century.

For further information, please contact:

Abe Dyck, Head of Corporate Development / Investor Relations
[email protected]
+1 226 784 8889

KCSA Strategic Communications
Jack Perkins, Senior Vice President
[email protected]

Forward Looking Statements

This news release contains forward-looking statements within the meaning of applicable Canadian and U.S. securities laws, including the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements in this release include, but are not limited to, statements regarding the proposed listing of the Company’s common shares on the TSX; the satisfaction of final TSX listing requirements; the expected timing of commencement of trading on the TSX; the expected delisting of the Company’s common shares from the CSE; the anticipated benefits of the TSX listing, including broader market visibility, increased access to institutional investors, and the continued development of the Company’s Canadian public-market profile; and the Company’s continued advancement of Hydrochemolytic™ Technology across waste plastics, heavy hydrocarbons, and renewable oils.

Forward-looking statements are based on management’s current expectations and assumptions, including assumptions regarding the Company’s ability to satisfy final TSX listing requirements; the receipt of all required documentation and approvals; the timing of the commencement of trading on the TSX; the delisting of the Company’s common shares from the CSE; the continued development and performance of Hydrochemolytic™ Technology; the availability of capital, permits, approvals, equipment, partners, and other resources required to support the Company’s development programs; the Company’s ability to execute its business plans and achieve its stated objectives; the Company’s ability to maintain and expand market visibility and investor access; and the stability of market, regulatory, and economic conditions.

These statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: the risk that final TSX approval may not be obtained or may be delayed; the risk that the commencement of trading on the TSX may not occur on the anticipated timeline or at all; the risk that the expected delisting from the CSE may be delayed or may not occur as anticipated; risks related to market conditions, trading liquidity, and investor interest; risks related to the development, scale-up, commercialization, and market acceptance of Hydrochemolytic™ Technology; technical, operational, permitting, financing, supply chain, and integration risks; risks related to feedstock availability and quality; regulatory, certification, and policy risks; competition; and other risks described in the Company’s public filings available at www.sedarplus.ca and www.sec.gov. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by applicable law, Aduro undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/33a335d1-8410-4dcb-877a-3fb64fe2124e

May 20, 2026 02:02 ET  | Source: Aduro Clean Technologies Inc.

LONDON, Ontario, 20 mai 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (« Aduro » ou la « Société ») (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société du secteur des technologies propres qui recycle chimiquement les matières premières de moindre valeur comme les déchets plastiques, le bitume lourd ou les huiles renouvelables en ressources adaptées au XXIe siècle, annonce avoir reçu l’approbation conditionnelle de la Bourse de Toronto (la « TSX ») pour la cotation de ses actions ordinaires sous le symbole « ACT ». L’approbation définitive de la cotation est subordonnée au respect par la Société de toutes les exigences de la TSX, y compris la réception de tous les documents requis.

La Société publiera un communiqué de presse dès que la TSX aura confirmé la date de négociation prévue. Dans le cadre de sa cotation à la TSX, la Société prévoit de retirer ses actions ordinaires de la cote de la Bourse canadienne des valeurs mobilières (la « CSE »). Les actionnaires ne sont pas tenus d’échanger leurs certificats d’actions et n’ont aucune autre formalité à accomplir relativement à cette cotation, car le symbole boursier et le code CUSIP des actions ordinaires demeureront inchangés.

« Depuis son introduction en bourse à la CSE en 2021, Aduro est passée du statut de jeune entreprise technologique à celui d’entreprise conceptrice de technologies chimiques cotée au Nasdaq, désormais dotée d’un bilan renforcé et de programmes de commercialisation industrielle en pleine expansion », a déclaré Ofer Vicus, directeur général d’Aduro. « La Société a fait progresser sa technologie Hydrochemolytic™ (HCT) grâce à des campagnes d’exploitation d’usines pilotes spécialisées dans des procédés de nouvelle génération (NGP), au développement de projets industriels novateurs (FOAK), à des engagements commerciaux d’achat, au développement d’offres de licences et à l’élargissement des applications pétrolières. Nous remercions sincèrement la CSE d’avoir constitué une plateforme clé pour notre croissance initiale sur les marchés boursiers et notre accès aux investisseurs, et nous nous réjouissons de poursuivre cette nouvelle étape aux côtés de la Bourse de Toronto, alors que nous poursuivons le développement de la technologie HCT pour le traitement des déchets plastiques, des hydrocarbures lourds et des huiles renouvelables. »

Aduro figure actuellement dans l’indice CSE25 qui regroupe les 25 plus grandes sociétés cotées à la Bourse canadienne des valeurs mobilières (CSE) en fonction de leur capitalisation boursière. Cette performance illustre la montée en puissance d’Aduro sur les marchés de capitaux ainsi que la reconnaissance que lui témoignent ses actionnaires pour les progrès constants réalisés depuis son introduction en bourse à la CSE. Ce projet de cotation à la TSX constitue une nouvelle phase dans l’évolution d’Aduro sur les marchés de capitaux. Elle lui assurera une plus grande visibilité sur les marchés, un accès accru aux investisseurs institutionnels et le développement continu de la notoriété de la Société sur le marché public canadien.

À propos d’Aduro Clean Technologies

Aduro Clean Technologies développe des technologies brevetées à base d’eau destinées à recycler chimiquement les déchets plastiques, convertir le pétrole brut lourd et le bitume en huile plus légère et à plus forte valeur, et transformer les huiles renouvelables en combustibles ou produits chimiques renouvelables à plus forte valeur ajoutée. La technologie Hydrochemolytic™ de la Société exploite l’eau comme agent essentiel d’une plateforme chimique fonctionnant à des températures et à des coûts relativement bas. Cette approche novatrice permet de convertir des matières premières à faible valeur ajoutée en ressources adaptées au XXIe siècle.

Pour tout complément d’informations, veuillez contacter :

Abe Dyck, responsable du développement d’entreprise et des relations investisseurs
[email protected]
+1 226 784 8889

KCSA Strategic Communications
Jack Perkins, vice-président principal
[email protected]

Déclarations prospectives

Le présent communiqué contient des déclarations prospectives au sens des lois canadiennes et américaines sur les valeurs mobilières, y compris la loi américaine Private Securities Litigation Reform Act de 1995. Les déclarations prospectives contenues dans le présent communiqué comprennent, sans toutefois s’y limiter, des déclarations concernant le projet de cotation des actions ordinaires de la Société à la TSX ; le respect des exigences finales de cotation à la TSX ; le calendrier prévu pour le début des négociations à la TSX ; le retrait prévu des actions ordinaires de la Société de la cote de la CSE ; les avantages anticipés de sa cotation à la TSX, notamment une plus grande visibilité sur les marchés, un accès accru aux investisseurs institutionnels et le développement continu de la notoriété de la Société sur le marché public canadien ; et les progrès continus de la technologie Hydrochemolytic™ de la Société pour le traitement des déchets plastiques, des hydrocarbures lourds et des huiles renouvelables.

Les déclarations prospectives reposent sur les attentes et hypothèses actuelles de la direction, notamment en ce qui concerne la capacité de la Société à satisfaire aux exigences finales de cotation à la TSX ; l’obtention de tous les documents et approbations requis ; le calendrier du début des négociations à la TSX ; le retrait des actions ordinaires de la Société de la cote de la CSE ; le développement et le rendement continus de la technologie Hydrochemolytic™ ; la disponibilité des capitaux, permis, approbations, équipements, partenaires et autres ressources nécessaires au soutien des programmes de développement de la Société ; la capacité de la Société à exécuter ses plans d’affaires et à atteindre ses objectifs ; sa capacité à maintenir et à accroître sa visibilité sur les marchés et son accès aux investisseurs ; et la stabilité des conditions économiques, réglementaires et de marché.

Ces déclarations sont assujetties à un certain nombre de risques et d’incertitudes qui pourraient entraîner des résultats réels sensiblement différents de ceux qui sont exprimés ou sous-entendus dans les présentes déclarations prospectives. Ces risques et incertitudes comprennent, sans toutefois s’y limiter : le risque que l’approbation finale de la TSX ne soit pas obtenue ou soit retardée ; le risque que le début des négociations à la TSX ne se produise pas dans les délais prévus ou ne se produise pas du tout ; le risque que le retrait prévu de la cote de la CSE soit retardé ou ne se produise pas comme prévu ; les risques liés aux conditions du marché, à la liquidité des transactions et à l’intérêt des investisseurs ; les risques liés au développement, au déploiement à grande échelle, à la commercialisation et à l’acceptation par le marché de la technologie Hydrochemolytic™ ; les risques techniques, opérationnels, d’autorisation, de financement, de chaîne d’approvisionnement et d’intégration ; les risques liés à la disponibilité et à la qualité des matières premières ; les risques réglementaires, de certification et d’évolution des politiques publiques ; la concurrence ; et les autres risques décrits dans les documents publics de la Société disponibles sur les sites Internet suivants : www.sedarplus.ca et www.sec.gov. Les lecteurs sont invités à ne pas accorder une confiance excessive aux déclarations prospectives. Aduro décline toute obligation de les actualiser ou de les réviser publiquement, que ce soit à la suite de nouvelles informations, d’événements futurs ou d’autres circonstances, sauf si la loi applicable l’exige.

Une photo annexée au présent communiqué est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/33a335d1-8410-4dcb-877a-3fb64fe2124e

Investors interested in Business Services stocks should always be looking to find the best-performing companies in the group. Is Aduro Clean Technologies Inc. (ADUR - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Business Services sector should help us answer this question.

Aduro Clean Technologies Inc. is one of 233 companies in the Business Services group. The Business Services group currently sits at #10 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Aduro Clean Technologies Inc. is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for ADUR's full-year earnings has moved 13.2% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Based on the latest available data, ADUR has gained about 37.8% so far this year. At the same time, Business Services stocks have lost an average of 10.6%. This means that Aduro Clean Technologies Inc. is performing better than its sector in terms of year-to-date returns.

Another stock in the Business Services sector, V2X (VVX - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 31.6%.

The consensus estimate for V2X's current year EPS has increased 8.5% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Breaking things down more, Aduro Clean Technologies Inc. is a member of the Technology Services industry, which includes 111 individual companies and currently sits at #168 in the Zacks Industry Rank. Stocks in this group have lost about 2.8% so far this year, so ADUR is performing better this group in terms of year-to-date returns. V2X is also part of the same industry.

Aduro Clean Technologies Inc. and V2X could continue their solid performance, so investors interested in Business Services stocks should continue to pay close attention to these stocks.

May 26, 2026 22:50 ET  | Source: Aduro Clean Technologies Inc.

LONDON, Ontario, May 27, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro“ oder das „Unternehmen“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Cleantech-Unternehmen, das mithilfe chemischer Verfahren minderwertige Ausgangsstoffe wie Kunststoffabfälle, Schwerbitumen und erneuerbare Öle in Ressourcen für das 21. Jahrhundert umwandelt, freut sich bekannt zu geben, dass es die endgültige Genehmigung für die Notierung seiner Stammaktien an der Toronto Stock Exchange („TSX“) unter dem Börsenkürzel „ACT“ erhalten hat. Der Handel an der TSX beginnt mit Eröffnung des Marktes am 27. Mai 2026.

Im Zusammenhang mit der Notierung an der TSX wird das Unternehmen seine Stammaktien gleichzeitig von der Canadian Securities Exchange („CSE“) delisten. Für Aktionäre besteht kein Handlungsbedarf; weder ein Umtausch der Aktienzertifikate noch sonstige Maßnahmen sind erforderlich, da sich weder das Börsenkürzel noch der CUSIP-Code der Stammaktien ändern. Die Stammaktien von Aduro werden weiterhin am Nasdaq Capital Market unter dem Kürzel „ADUR“ und an der Frankfurter Wertpapierbörse unter dem Kürzel „9D5“ gehandelt.

Die TSX ist der führende Aktienmarkt in Kanada und einer der weltweit führenden öffentlichen Aktienmärkte. Nach Angaben der TMX Group zählte die TSX im April 2026 2.176 börsennotierte Emittenten und wies eine Marktkapitalisierung der notierten Wertpapiere von rund 6,8 Billionen kanadischen Dollar auf, verteilt auf ein breites Spektrum von Sektoren, darunter Rohstoffe, Finanzwesen, Industrie, Technologie und saubere Technologien. Die Börsennotierung stellt den nächsten Schritt in der Entwicklung von Aduro auf den kanadischen Kapitalmärkten dar und bringt das Börsenprofil des Unternehmens in Kanada mit seiner breiteren Präsenz an den öffentlichen Märkten in den Vereinigten Staaten und Europa in Einklang.

Aduro wurde zuvor an der CSE gehandelt und war im CSE25-Index vertreten, einem Referenzindex der 25 nach Marktkapitalisierung größten Unternehmen der Börse. Das Unternehmen würdigt die Rolle, die die CSE bei der Unterstützung seines Wachstums und seiner Entwicklung in der Anfangsphase an der Börse gespielt hat.

Die Notierung an der TSX dürfte die nächste Phase der Kapitalmarktentwicklung des Unternehmens unterstützen, indem sie Folgendes bietet:

Anerkennung als Senior Exchange: Durch die Notierung an der TSX wird Aduro in den Markt für Senior-Aktien in Kanada aufgenommen, was den erfolgreichen Abschluss des entsprechenden Zulassungsverfahrens durch das Unternehmen widerspiegelt.Breiterer institutioneller Zugang: Die TSX genießt bei kanadischen und internationalen institutionellen Anlegern hohes Ansehen. Es wird erwartet, dass die Notierung die Sichtbarkeit von Aduro im Rahmen institutioneller Anlagemandate, Research-Plattformen und Kapitalmarktprozessen verbessert, einschließlich Mandaten, die Emittenten an führenden Börsen den Vorzug geben.Verbesserte Handelsinfrastruktur: An der TSX notierte Wertpapiere profitieren von Kanadas etablierter Aktienmarktinfrastruktur, darunter effizienter Zugang zu Liquidität, hochwertige Ausführung, breitere Beteiligung von Broker-Dealern, Unterstützung durch Market-Maker sowie Sichtbarkeit in institutionellen Handelssystemen.Kriterien für die Aufnahme in einen Index: Durch die Notierung an der TSX wird Aduro einer Prüfung anhand der geltenden kanadischen Kriterien für die Aufnahme in einen Index unterzogen, darunter Kriterien in Bezug auf Marktkapitalisierung, Handelsliquidität, Streubesitz sowie weitere Anforderungen auf Emittentebene. Die Aufnahme in einen Index erfolgt nicht automatisch und hängt von der jeweiligen Indexmethodik sowie der künftigen Wertentwicklung des Unternehmens ab.Marktpräsenz und Auffindbarkeit in der Research-Landschaft: Die Notierung an der TSX dürfte die Präsenz von Aduro auf den kanadischen Kapitalmärkten stärken und die Auffindbarkeit für institutionelle Anleger, Analysten, Wertpapierhändler und Finanzmedien verbessern.Erreichbarkeit von Investoren in verschiedenen Märkten: Durch die Notierung an der Toronto Stock Exchange, dem Nasdaq Capital Market und der Frankfurter Wertpapierbörse sichert sich Aduro im Zuge der weiteren Kommerzialisierung Zugang zu Investorenkreisen in Kanada, den Vereinigten Staaten und Europa. „Die Aufnahme des Handels an der Toronto Stock Exchange ist ein wichtiger Meilenstein in der Kapitalmarktentwicklung von Aduro und spiegelt die Fortschritte wider, die das Unternehmen seit seinem Börsengang in Kanada erzielt hat“, erklärt Ofer Vicus, Chief Executive Officer von Aduro. „Während wir die Betriebsphasen der NGP-Pilotanlage, die industrielle Planung für das FOAK-Projekt und die kommerzielle Vermarktung unserer Hydrochemolytic™-Technologie vorantreiben, bietet die Notierung an der TSX eine hochrangige Plattform auf dem kanadischen Markt, die besser zur aktuellen Entwicklungsphase von Aduro und zum internationalen Investorenprofil passt. Wir sind der Canadian Securities Exchange dankbar dafür, dass sie das frühe Wachstum von Aduro an der Börse unterstützt hat, und wir danken unseren Aktionären, Partnern und dem Aduro-Team dafür, dass sie uns dabei geholfen haben, diesen nächsten Meilenstein zu erreichen.“

Über Aduro Clean Technologies

Aduro Clean Technologies entwickelt patentierte wasserbasierte Technologien zur chemischen Wiederverwertung von Kunststoffabfällen, zur Umwandlung von Schweröl und Bitumen in leichtere und wertvollere Ölprodukte sowie zur Veredelung erneuerbarer Öle zu höherwertigen Kraftstoffen oder erneuerbaren Chemikalien. Die Hydrochemolytic™-Technologie des Unternehmens nutzt Wasser als wichtigstes Prozessmedium in einer chemischen Plattform, die bei relativ niedrigen Temperaturen und zu relativ niedrigen Kosten arbeitet. Dabei handelt es sich um einen bahnbrechenden Ansatz, der minderwertige Rohstoffe in Ressourcen für das 21. Jahrhundert umwandelt.

Für weitere Informationen wenden Sie sich bitte an:

Abe Dyck, Head of Corporate Development / Investor Relations
[email protected]
+1 226 784 8889

KCSA Strategic Communications
Jack Perkins, Senior Vice President
[email protected]

Zukunftsgerichtete Aussagen

Diese Pressemitteilung enthält zukunftsgerichtete Aussagen im Sinne der geltenden kanadischen und US-amerikanischen Wertpapiergesetze, einschließlich des US-amerikanischen Private Securities Litigation Reform Act von 1995. Zukunftsgerichtete Aussagen in dieser Pressemitteilung umfassen unter anderem Aussagen zum voraussichtlichen Zeitpunkt der Aufnahme des Handels an der TSX; zum erwarteten Delisting der Stammaktien des Unternehmens von der CSE; die erwarteten Vorteile der Notierung an der TSX, darunter die Anerkennung als führende Börse, ein breiterer Zugang für institutionelle Anleger, eine verbesserte Handelsinfrastruktur, Möglichkeiten zur Aufnahme in Indizes, Marktpräsenz, Auffindbarkeit in Research-Berichten sowie der fortgesetzte Zugang zu Investorengemeinschaften in Kanada, den Vereinigten Staaten und Europa; sowie die Weiterentwicklung der Hydrochemolytic™-Technologie des Unternehmens und des Kommerzialisierungswegs.

Zukunftsgerichtete Aussagen beruhen auf den aktuellen Erwartungen und Annahmen des Managements, einschließlich Annahmen hinsichtlich des Zeitpunkts der Aufnahme des Handels an der TSX; des Delistings der Stammaktien des Unternehmens von der CSE; der Weiterentwicklung und Leistungsfähigkeit der Hydrochemolytic™-Technologie; der Verfügbarkeit von Kapital, Genehmigungen, Zulassungen, Ausrüstung, Partnern und anderen Ressourcen, die zur Unterstützung der Entwicklungsprogramme des Unternehmens erforderlich sind; der Fähigkeit des Unternehmens, seine Geschäftspläne umzusetzen und die erklärten Ziele zu erreichen; der Fähigkeit des Unternehmens, seine Marktpräsenz, den Zugang zu Investoren, die Handelsliquidität und die Einbindung in die Kapitalmärkte aufrechtzuerhalten und auszubauen; sowie der Stabilität der Markt-, Regulierungs- und Wirtschaftsbedingungen.

Diese Aussagen unterliegen Risiken und Unsicherheiten, die dazu führen können, dass die tatsächlichen Ergebnisse wesentlich von den in diesen zukunftsgerichteten Aussagen ausgedrückten oder implizierten Ergebnissen abweichen. Zu diesen Risiken und Ungewissheiten zählen unter anderem: das Risiko, dass die Aufnahme des Handels an der TSX nicht zum vorgesehenen Zeitpunkt oder gar nicht erfolgt; das Risiko, dass sich das erwartete Delisting von der CSE verzögert oder nicht wie vorgesehen erfolgt; Risiken im Zusammenhang mit Marktbedingungen, Handelsliquidität, Anlegerinteresse, Analystenabdeckung, Indexzulassung und Beteiligung institutioneller Anleger; Risiken im Zusammenhang mit der Entwicklung, Skalierung, Kommerzialisierung und Marktakzeptanz der Hydrochemolytic™-Technologie; technische, betriebliche, genehmigungsrechtliche, finanzierungsbezogene, Lieferketten- und Integrationsrisiken; Risiken im Zusammenhang mit der Verfügbarkeit und Qualität von Rohstoffen; regulatorische, Zertifizierungs- und politische Risiken; Wettbewerb; sowie sonstige Risiken, die in den öffentlichen Einreichungen des Unternehmens beschrieben sind, die unter www.sedarplus.ca und www.sec.gov beschrieben sind. Die Leser werden ausdrücklich darauf hingewiesen, kein unangemessenes Vertrauen in zukunftsgerichtete Aussagen zu setzen. Sofern nicht durch geltendes Recht vorgeschrieben, ist Aduro nicht verpflichtet, zukunftsgerichtete Aussagen zu aktualisieren oder zu überarbeiten, sei es aufgrund neuer Informationen, zukünftiger Ereignisse oder aus anderen Gründen.

Ein Foto zu dieser Mitteilung ist verfügbar unter:
https://www.globenewswire.com/NewsRoom/AttachmentNg/f992198e-98cf-483a-b09d-8417b49e591c

LONDON, Ontario, May 28, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announces its participation in several industry and investor conferences in June 2026. The program includes one-on-one institutional investor meetings in London UK, a Toronto Stock Exchange-hosted investor event in Canada, and two technical conferences.

Conference and Trade Program Highlights:

One-on-one institutional investor meetings at the 16th Annual ROTH London Conference, with CEO Ofer Vicus and CFO Mena Beshay representing Aduro, continuing engagement with international institutional investors following the Company’s participation at the 38th Annual ROTH Conference earlier this year.Investor presentation and panel participation at the Canadian Climate Investor Conference, hosted by Toronto Stock Exchange and TSX Venture Exchange, marking Aduro’s first TSX-hosted investor event following the Company’s recent listing on the Toronto Stock Exchange under the symbol “ACT.”Technical presentation at AMI Chemical Recycling Europe 2026 in Frankfurt, focused on Hydrochemolytic™ Technology, carbon efficiency, feedstock flexibility, product quality, and downstream integration requirements for chemical recycling deployment.Technical presentation at Future of Advanced Recycling North America 2026 in Pittsburgh, focused on the practical requirements for scaling advanced recycling projects across the value chain.
AMI Chemical Recycling Europe 2026 brings together participants across the chemical recycling value chain, including technology developers, polymer producers, recyclers, converters, brand owners, and downstream users evaluating the technical and commercial requirements for industrial deployment. Eric Appelman will present on Aduro’s Hydrochemolytic™ Technology (“HCT”) and the progress in advancing from pilot-scale validation toward first-of-a-kind (“FOAK”) industrial planning, with a focus on carbon efficiency, feedstock flexibility, product quality, and downstream integration requirements. Aduro’s participation supports ongoing European market development and engagement with industry participants relevant to the Company’s planned FOAK industrial facility at Chemelot.

The Canadian Climate Investor Conference, hosted by Toronto Stock Exchange and TSX Venture Exchange, brings together growth-oriented clean technology and renewable energy companies with climate-conscious investors to explore opportunities to accelerate capital deployment toward climate-related solutions. The event includes company presentations, sector-specific moderated panels, and opportunities for investors to connect with clean technology companies and executive teams.

Aduro’s participation follows the Company’s recent listing on the Toronto Stock Exchange under the symbol “ACT,” providing a timely opportunity to introduce the Company’s progress to Canadian climate-focused investors. Abe Dyck will present Aduro’s business and participate in a panel with other Canadian climate technology companies, discussing the role of Hydrochemolytic™ Technology in addressing hard-to-recycle plastics, improving resource efficiency, and supporting industrial circularity, alongside the Company’s stepwise commercialization pathway, which includes NGP Pilot Plant operating campaigns, FOAK project planning, and commercialization initiatives.

The 16th Annual ROTH London Conference provides institutional investors with access to executive management teams from more than 80 companies through one-on-one and small group meetings designed to support in-depth investor interaction. Ofer Vicus and Mena Beshay will participate in scheduled investor meetings, providing updates on Aduro’s NGP Pilot Plant operating campaigns, FOAK industrial facility planning, commercial engagement, and balance sheet position. Aduro’s participation supports continued engagement with international institutional investors as the Company advances from pilot-scale validation toward FOAK industrial execution.

Future of Advanced Recycling North America 2026 is focused on the practical requirements for delivering advanced recycling projects that are commercially viable, financeable, and credible at scale, with discussion topics including feedstock security, regulatory treatment, technology performance, financing, market demand, product quality, claims, and value-chain coordination. Eric Appelman will present Hydrochemolytic™ Technology and the Company’s approach to advancing from pilot-scale validation toward FOAK industrial deployment. In advance of the conference, Eric also participated in a short event interview highlighting Aduro’s participation in the program. The presentation will focus on Aduro’s efforts to move advanced recycling beyond announcements by generating operating data, validating product pathways, aligning with downstream requirements, and building the partnerships needed for credible commercial implementation.

In addition to scheduled participation across these events, Aduro expects to hold meetings throughout the conferences and trade programs. Interested parties are encouraged to contact the respective organizers or email [email protected] to arrange one-on-one meetings.

About Aduro Clean Technologies

Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company’s Hydrochemolytic™ Technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century.

For further information, please contact:

Abe Dyck, Head of Corporate Development and Investor Relations
[email protected]
+1 226 784 8889

Forward Looking Statements

This news release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements regarding Aduro’s expected participation in industry and investor conferences in June 2026, anticipated presentations, panel participation, investor meetings, industry discussions, and the expected benefits of these activities. Forward-looking statements also include statements related to the Company’s development programs, including NGP Pilot Plant operating campaigns, FOAK industrial facility planning, commercialization initiatives, offtake alignment, licensing package development, and the potential role of Hydrochemolytic™ Technology in waste plastics, heavy bitumen, and renewable oils applications.

Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including changes in conference scheduling or format, market conditions, investor interest, industry engagement, the Company’s ability to execute its development and commercialization plans, the progression of Pilot Plant operations, advancement of the FOAK project, partner engagement, offtake and licensing discussions, and other risks described in the Company’s filings available on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov.

The Company disclaims any intention or obligation to update or revise any forward-looking statements, except as required by applicable law.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/48eb5432-6e8e-433b-a8e0-49a20bbaee48

May 29, 2026 10:58 ET  | Source: Aduro Clean Technologies Inc.

LONDON, Ontario, May 29, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro“ oder das „Unternehmen“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Cleantech-Unternehmen, das mithilfe chemischer Prozesse minderwertige Einsatzstoffe wie Kunststoffabfälle, Schwerbitumen und erneuerbare Öle in Ressourcen für das 21. Jahrhundert umwandelt, hat heute seine Teilnahme an mehreren Branchen- und Investorenkonferenzen im Juni 2026 bekannt gegeben. Das Programm umfasst Einzelgespräche mit institutionellen Investoren in London im Vereinigten Königreich, eine von der Toronto Stock Exchange ausgerichtete Investorenveranstaltung in Kanada sowie zwei Fachkonferenzen.

Höhepunkte des Konferenz- und Handelsprogramms:

Einzelgespräche mit institutionellen Investoren im Rahmen der 16. jährlichen ROTH London Conference, auf der CEO Ofer Vicus und CFO Mena Beshay Aduro vertreten sind. Damit setzt das Unternehmen nach seiner Teilnahme an der 38. jährlichen ROTH Conference Anfang dieses Jahres den Austausch mit internationalen institutionellen Investoren fort.Investorenpräsentation und Teilnahme an einer Podiumsdiskussion auf der Canadian Climate Investor Conference, veranstaltet von der Toronto Stock Exchange und der TSX Venture Exchange. Dies ist Aduros erste von der TSX ausgerichtete Investorenveranstaltung seit der kürzlich erfolgten Notierung des Unternehmens an der Toronto Stock Exchange unter dem Symbol „ACT“.Fachvortrag auf der AMI Chemical Recycling Europe 2026 in Frankfurt mit Schwerpunkt auf der Hydrochemolytic™ Technology, der Kohlenstoffeffizienz, der Flexibilität bei den Einsatzstoffen, der Produktqualität und den Anforderungen an die nachgelagerte Integration bei der industriellen Umsetzung des chemischen Recyclings.Fachvortrag auf der Future of Advanced Recycling North America 2026 in Pittsburgh mit Schwerpunkt auf den praktischen Anforderungen für die Skalierung von Advanced-Recycling-Projekten entlang der gesamten Wertschöpfungskette.
Die AMI Chemical Recycling Europe 2026 bringt Akteure aus der gesamten Wertschöpfungskette des chemischen Recyclings zusammen, darunter Technologieentwickler, Polymerhersteller, Recycler, Verarbeiter, Markeninhaber und nachgelagerte Anwender, die die technischen und kommerziellen Anforderungen für die industrielle Umsetzung bewerten. Eric Appelman wird Aduros Hydrochemolytic™ Technology („HCT“) sowie die Fortschritte auf dem Weg von der Validierung auf Pilotebene zur Planung einer First-of-a-Kind-Anlage („FOAK“) vorstellen, mit Schwerpunkt auf Kohlenstoffeffizienz, Flexibilität bei den Einsatzstoffen, Produktqualität und den Anforderungen an die nachgelagerte Integration. Aduros Teilnahme unterstützt die laufende Marktentwicklung in Europa sowie den Austausch mit Branchenakteuren, die für die geplante FOAK-Industrieanlage des Unternehmens in Chemelot relevant sind.

Die Canadian Climate Investor Conference, veranstaltet von der Toronto Stock Exchange und der TSX Venture Exchange, bringt wachstumsorientierte Unternehmen aus den Bereichen Cleantech und erneuerbare Energien mit klimabewussten Investoren zusammen, um Möglichkeiten auszuloten, den Kapitaleinsatz für klimabezogene Lösungen zu beschleunigen. Die Veranstaltung umfasst Unternehmenspräsentationen, branchenspezifische moderierte Podiumsdiskussionen sowie Gelegenheiten für Investoren, mit Cleantech-Unternehmen und deren Führungsteams in Kontakt zu treten.

Aduros Teilnahme folgt auf die kürzlich erfolgte Notierung des Unternehmens an der Toronto Stock Exchange unter dem Symbol „ACT“ und bietet eine günstige Gelegenheit, kanadischen klimafokussierten Investoren die Fortschritte des Unternehmens vorzustellen. Abe Dyck wird Aduros Geschäft vorstellen und an einer Podiumsdiskussion mit anderen kanadischen Klimatechnologieunternehmen teilnehmen. Dabei wird er die Rolle der Hydrochemolytic™ Technology bei der Bewältigung schwer recycelbarer Kunststoffe, der Verbesserung der Ressourceneffizienz und der Förderung der industriellen Kreislaufführung erläutern. Außerdem wird er den schrittweisen Weg des Unternehmens zur Kommerzialisierung vorstellen, der Betriebskampagnen der NGP-Pilotanlage, die Planung des FOAK-Projekts und Kommerzialisierungsinitiativen umfasst.

Die 16. Annual ROTH London Conference bietet institutionellen Investoren Zugang zu den Führungsteams von mehr als 80 Unternehmen im Rahmen von Einzel- und Kleingruppengesprächen, die einen vertieften Austausch mit Investoren ermöglichen sollen. Ofer Vicus und Mena Beshay werden an geplanten Investorengesprächen teilnehmen und über den aktuellen Stand der Betriebskampagnen der NGP-Pilotanlage von Aduro, die Planung der FOAK-Industrieanlage, die kommerziellen Aktivitäten sowie die Bilanzlage berichten. Aduros Teilnahme unterstützt den fortgesetzten Austausch mit internationalen institutionellen Investoren, während das Unternehmen den Übergang von der Validierung auf Pilotebene zur industriellen Umsetzung einer FOAK-Anlage vorantreibt.

Future of Advanced Recycling North America 2026 konzentriert sich auf die praktischen Anforderungen für die Umsetzung von Advanced-Recycling-Projekten, die kommerziell tragfähig, finanzierbar und im großen Maßstab belastbar sind. Zu den Diskussionsthemen gehören die Versorgungssicherheit bei den Einsatzstoffen, die regulatorische Einordnung, die technische Leistungsfähigkeit, Finanzierung, Marktnachfrage, Produktqualität, Produkt- und Nachhaltigkeitsaussagen sowie die Koordination entlang der Wertschöpfungskette. Eric Appelman wird die Hydrochemolytic™ Technology sowie den Ansatz des Unternehmens vorstellen, den Übergang von der Validierung auf Pilotebene zur industriellen Umsetzung einer FOAK-Anlage voranzutreiben. Im Vorfeld der Konferenz nahm Eric zudem an einem kurzen Interview im Vorfeld der Veranstaltung teil, in dem er Aduros Teilnahme am Programm hervorhob. Im Mittelpunkt der Präsentation stehen Aduros Bemühungen, Advanced Recycling über bloße Ankündigungen hinauszubringen, indem Betriebsdaten generiert, Produktpfade validiert, nachgelagerte Anforderungen berücksichtigt und die für eine belastbare kommerzielle Umsetzung erforderlichen Partnerschaften aufgebaut werden.

Zusätzlich zur geplanten Teilnahme an diesen Veranstaltungen erwartet Aduro, während der Konferenzen und Handelsprogramme weitere Meetings abzuhalten. Interessenten werden gebeten, sich an die jeweiligen Veranstalter zu wenden oder eine E-Mail an [email protected] zu senden, um Einzelgespräche zu vereinbaren.

Über Aduro Clean Technologies

Aduro Clean Technologies entwickelt patentierte wasserbasierte Technologien zur chemischen Wiederverwertung von Kunststoffabfällen, zur Umwandlung von Schweröl und Bitumen in leichtere und wertvollere Ölprodukte sowie zur Veredelung erneuerbarer Öle zu höherwertigen Kraftstoffen oder erneuerbaren Chemikalien. Die Hydrochemolytic™-Technologie des Unternehmens nutzt Wasser als wichtigstes Prozessmedium in einer chemischen Plattform, die bei relativ niedrigen Temperaturen und zu relativ niedrigen Kosten arbeitet. Dabei handelt es sich um einen bahnbrechenden Ansatz, der minderwertige Rohstoffe in Ressourcen für das 21. Jahrhundert umwandelt.

Für weitere Informationen wenden Sie sich bitte an:

Abe Dyck, Head of Corporate Development and Investor Relations
[email protected]
+1 226 784 8889

Zukunftsgerichtete Aussagen

Diese Pressemitteilung enthält zukunftsgerichtete Aussagen im Sinne der geltenden Wertpapiergesetze. Zukunftsgerichtete Aussagen umfassen unter anderem Aussagen zur erwarteten Teilnahme von Aduro an Branchen- und Investorenkonferenzen im Juni 2026, zu geplanten Präsentationen, zur Teilnahme an Podiumsdiskussionen, zu Investorengesprächen, zu Branchendiskussionen sowie zu den erwarteten Vorteilen dieser Aktivitäten. Zukunftsgerichtete Aussagen umfassen auch Aussagen zu den Entwicklungsprogrammen des Unternehmens, einschließlich der Betriebskampagnen der NGP-Pilotanlage, der Planung der FOAK-Industrieanlage, der Kommerzialisierungsinitiativen, der Abstimmung von Abnahmevereinbarungen, der Entwicklung von Lizenzierungspaketen sowie der potenziellen Rolle der Hydrochemolytic™ Technology bei Anwendungen mit Kunststoffabfällen, schwerem Bitumen und erneuerbaren Ölen.

Zukunftsgerichtete Aussagen basieren auf den aktuellen Erwartungen des Managements und unterliegen Risiken und Ungewissheiten, die dazu führen könnten, dass die tatsächlichen Ergebnisse wesentlich abweichen. Dazu zählen unter anderem Änderungen beim Zeitplan oder Format von Konferenzen, Marktbedingungen, das Interesse von Investoren, das Engagement der Branche, die Fähigkeit des Unternehmens, seine Entwicklungs- und Kommerzialisierungspläne umzusetzen, der Fortschritt des Pilotanlagenbetriebs, die Weiterentwicklung des FOAK-Projekts, die Einbindung von Partnern, Gespräche über Abnahmevereinbarungen und Lizenzen sowie weitere Risiken, die in den auf SEDAR+ unter www.sedarplus.ca und EDGAR unter www.sec.gov verfügbaren Unternehmensunterlagen beschrieben sind.

Das Unternehmen übernimmt keine Verpflichtung, zukunftsgerichtete Aussagen zu aktualisieren oder zu revidieren, sofern dies nicht nach geltendem Recht erforderlich ist.

Ein Foto zu dieser Mitteilung ist verfügbar unter https://www.globenewswire.com/NewsRoom/AttachmentNg/48eb5432-6e8e-433b-a8e0-49a20bbaee48

For those looking to find strong Business Services stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Aduro Clean Technologies Inc. (ADUR - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.

Aduro Clean Technologies Inc. is one of 234 companies in the Business Services group. The Business Services group currently sits at #7 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Aduro Clean Technologies Inc. is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for ADUR's full-year earnings has moved 12.4% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

According to our latest data, ADUR has moved about 35.3% on a year-to-date basis. Meanwhile, stocks in the Business Services group have lost about 11.2% on average. This means that Aduro Clean Technologies Inc. is performing better than its sector in terms of year-to-date returns.

Concrete Pumping (BBCP - Free Report) is another Business Services stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 55.4%.

The consensus estimate for Concrete Pumping's current year EPS has increased 112.5% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Looking more specifically, Aduro Clean Technologies Inc. belongs to the Technology Services industry, a group that includes 112 individual stocks and currently sits at #155 in the Zacks Industry Rank. Stocks in this group have lost about 0.7% so far this year, so ADUR is performing better this group in terms of year-to-date returns.

Concrete Pumping, however, belongs to the Waste Removal Services industry. Currently, this 20-stock industry is ranked #94. The industry has moved -4.9% so far this year.

Going forward, investors interested in Business Services stocks should continue to pay close attention to Aduro Clean Technologies Inc. and Concrete Pumping as they could maintain their solid performance.

LONDON, Ontario, June 10, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced:

(i)    an underwritten U.S. and Canadian public offering (the “Public Offering”) of 1,028,645 common shares at a price of US$15.20 (C$21.20) per common share (the “Offering Price”) for gross proceeds to the Company, under the Public Offering, of US$15,635,404, before deducting underwriting discounts and Public Offering expenses; and
(ii)   a concurrent non-brokered private placement (the “LIFE Offering”) of up to 471,698 common shares at the Offering Price per common share for gross proceeds to the Company, under the LIFE Offering, of up to US$7,169,810, before deducting any finder’s fees and other LIFE Offering expenses,

for aggregate gross proceeds to the Company of up to US$22,805,214 (collectively, the “Offering”), before deducting discounts, fees and other Offering expenses.

Canaccord Genuity is acting as sole bookrunner for the Public Offering. In connection with the Public Offering, the Company entered into an underwriting agreement with Canaccord Genuity, as representative of the several underwriters in the Public Offering (the “Underwriting Agreement”).

Aduro intends to use the net proceeds from the Offering for expenditures related to the design, engineering and construction of first-of-a-kind demonstration-scale industrial plant (the “FOAK Plant”), ongoing research and development costs and the remainder for general corporate purposes and working capital. The Public Offering is expected to close on or about June 11, 2026 (the “Closing Date”), subject to the satisfaction of customary closing conditions including the listing of the offered common shares on the Toronto Stock Exchange (the “TSX”) and the Nasdaq Capital Market (the “Nasdaq”) and any required approvals of the TSX and Nasdaq. The Public Offering is not conditional on the closing of the LIFE Offering, and the LIFE Offering is not conditional on the closing of the Public Offering. The LIFE Offering is expected to close on or about the Closing Date, or such other date as the Company may determine, and, in any event, on or before a date not later than 45 days after the date hereof. The LIFE Offering may close in one or more tranches.

The Public Offering is being made pursuant to an effective shelf registration statement on Form F-10, as amended (File No. 333-292023), previously filed with the U.S. Securities and Exchange Commission (“SEC”) on December 15, 2025 and became effective upon filing, and the Company’s Canadian short form base shelf prospectus dated December 15, 2025 (the “Base Shelf Prospectus”) and an accompanying prospectus supplement to the Base Shelf Prospectus (the “Prospectus Supplement”, and together with the Base Shelf Prospectus, the “Final Prospectus”).

The Base Shelf Prospectus relating to the Public Offering and describing the terms thereof has been filed with the securities regulatory authorities in British Columbia and Ontario and with the SEC in the United States and is available for free by visiting the Company’s profiles on the SEDAR+ website maintained by the Canadian Securities Administrators at www.sedarplus.ca or the SEC’s website at www.sec.gov, as applicable. The Prospectus Supplement will be filed with the securities regulatory authorities in British Columbia and Ontario and the SEC. Copies of the Final Prospectus may be obtained, when available, at the SEC’s website at www.sec.gov or from Canaccord Genuity LLC, Attn: Syndication Department, 1 Post Office Square, 30th Floor, Boston, MA 02109, or by email at [email protected].

Before you invest, you should read the Final Prospectus and other documents the Company has filed or will file with the with the securities regulatory authorities in British Columbia and Ontario and the SEC, for more complete information about the Company and the Offering.

The LIFE Offering is being made to purchasers resident in all provinces of Canada, except Québec, pursuant to the listed issuer financing exemption from the prospectus requirement available under Part 5A of National Instrument 45-106 – Prospectus Exemptions and Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption of the Canadian Securities Administrators (collectively, the “LIFE Exemption”). Subject to compliance with the terms of the LIFE Exemption, the common shares offered under the LIFE Exemption (the “LIFE Shares”) will not be subject to resale restrictions pursuant to applicable Canadian securities laws. In addition, the LIFE Shares may be offered for sale on a private placement basis pursuant to available exemptions from the registration or prospectus requirements to investors resident in certain other jurisdictions outside of Canada and the United States; provided it is understood that the Company will not be required to register or make any filings (other than reports on sales of securities in the United States and Canada) in such jurisdictions.

There is an offering document related to this LIFE Offering that can be accessed under the Company’s profile at www.sedarplus.com and on the Company’s website at www.adurocleantech.com. Prospective investors should read this offering document before making an investment decision.

The Company anticipates certain insiders of the Company may participate in the LIFE Offering. Any participation in the LIFE Offering by insiders constitutes a “related party transaction” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). However, the Company expects to rely on exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 based on the fact neither the fair market value of the LIFE Shares subscribed for by the insiders, nor the consideration for the LIFE Shares paid by such insiders, would exceed 25% of the Company’s market capitalization as at the date of this press release.

The Company intends to rely upon the exemption set forth in Section 602.1 of the TSX Company Manual in connection with the Offering, which provides that the TSX will not apply its standards to certain transactions involving eligible interlisted issuers on a recognized exchange.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy any of the Company’s securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company’s securities in any state or jurisdiction in which such offers, solicitations or sales would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. None of the LIFE Shares will be registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold in the United States absent registration or an exemption from registration.

All amounts in this press release are in United States dollars unless otherwise indicated. All foreign exchange calculations set forth in this press release is based on the exchange rate posted by the Bank of Canada on June 9, 2026 of US$1 = C$1.3947.

About Aduro Clean Technologies

Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company’s Hydrochemolytic™ technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century.

For further information, please contact:

Abe Dyck, Head of Corporate Development / Investor Relations
[email protected]
+1 226 784 8889

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of applicable United States securities laws, and “forward-looking information” within the meaning of Canadian securities laws (collectively, “forward-looking statements”). All statements, other than statements of historical facts, included in this press release are forward-looking statements. The material factors and assumptions used to develop the forward-looking statements contained in this press release include the following: our understanding and belief of the current market conditions, approved business plans and regulatory approvals with respect to the FOAK Plant and other pilot plants, continued positive research and development results, results of our test work for technological and process improvements, our experience with regulators, and continuation of positive economic conditions. When used in this press release or otherwise, the words “plan”, “potential,” “indicate,” “expect,” “intend,” “believe,” “may,” “will,” “if,” “anticipate,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements include, without limitation, references to the Company’s expectations regarding the closing of each of the Public Offering and satisfaction of conditions precedent in the Underwriting Agreement, closing of the LIFE Offering and satisfaction of conditions precedent to any subscription agreement entered into in connection therewith, the receipt of all regulatory approvals (including of the TSX and Nasdaq) for the Public Offering and the LIFE Offering, the anticipated gross proceeds of the Public Offering and the LIFE Offering, and its anticipated use of net proceeds from the Public Offering and LIFE Offering. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the satisfaction of customary closing conditions related to the Public Offering and the LIFE Offering, receipt of all regulatory approvals therefor, or other factors that result in changes to the Company’s anticipated use of proceeds, including those which may affect the Company’s expectations with respect to its FOAK Plant or other pilot plants. These and other risks and uncertainties are described more fully in the section captioned “Risk Factors” in the Company’s Base Shelf Prospectus, Prospectus Supplement, management discussion and analyses, and its annual information form dated August 27, 2025, all of which is or will be available on SEDAR+ at www.sedarplus.ca, and on EDGAR at www.sec.gov. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law, including the securities laws of the United States and Canada.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5eda16f6-3feb-409b-be2b-c9943a626097

Aberdeen Group plc lessened its stake in Camden Property Trust (NYSE: CPT) by 12.4% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 235,525 shares of the real estate investment trust's stock after selling 33,468 shares during the period. Aberdeen Group

Rates are stuck, and most high-yield investors are positioned all wrong. I provide a detailed sector-by-sector breakdown of exactly where smart money is moving right now, including specific blue-chip picks trading at deep discounts. I also detail my disciplined capital recycling approach to accelerate my income and total return compounding in the current environment.

Posted by Defense World Staff on Apr 16th, 2026

Consolidated Investment Group LLC increased its position in Camden Property Trust (NYSE:CPT – Free Report) by 27.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,900 shares of the real estate investment trust’s stock after buying an additional 5,000 shares during the period. Consolidated Investment Group LLC’s holdings in Camden Property Trust were worth $2,521,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in CPT. Abich Financial Wealth Management LLC purchased a new stake in shares of Camden Property Trust in the third quarter worth about $25,000. Quent Capital LLC purchased a new stake in shares of Camden Property Trust in the third quarter worth about $29,000. Hantz Financial Services Inc. lifted its position in shares of Camden Property Trust by 524.4% in the third quarter. Hantz Financial Services Inc. now owns 281 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 236 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new stake in shares of Camden Property Trust in the second quarter worth about $32,000. Finally, Fulcrum Asset Management LLP purchased a new stake in shares of Camden Property Trust in the third quarter worth about $32,000. 97.22% of the stock is currently owned by hedge funds and other institutional investors.

Camden Property Trust Trading Down 0.4% Shares of CPT stock opened at $101.37 on Thursday. Camden Property Trust has a 1 year low of $96.53 and a 1 year high of $121.33. The company has a debt-to-equity ratio of 0.88, a current ratio of 0.14 and a quick ratio of 0.14. The stock’s 50 day simple moving average is $103.84 and its two-hundred day simple moving average is $104.82. The company has a market cap of $10.62 billion, a PE ratio of 28.63, a price-to-earnings-growth ratio of 6.93 and a beta of 0.83.

Camden Property Trust (NYSE:CPT – Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $1.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.73 by ($0.29). Camden Property Trust had a net margin of 24.43% and a return on equity of 8.36%. The company had revenue of $396.08 million for the quarter, compared to analysts’ expectations of $393.05 million. During the same quarter last year, the company earned $1.73 earnings per share. The company’s revenue for the quarter was up 1.2% on a year-over-year basis. Camden Property Trust has set its Q1 2026 guidance at 1.640-1.680 EPS and its FY 2026 guidance at 6.600-6.900 EPS. Research analysts predict that Camden Property Trust will post 6.76 earnings per share for the current year.

Camden Property Trust announced that its Board of Directors has authorized a stock repurchase program on Thursday, February 5th that allows the company to repurchase $600.00 million in outstanding shares. This repurchase authorization allows the real estate investment trust to repurchase up to 5.2% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.

Camden Property Trust Increases Dividend The firm also recently declared a quarterly dividend, which will be paid on Friday, April 17th. Stockholders of record on Tuesday, March 31st will be issued a $1.06 dividend. The ex-dividend date is Tuesday, March 31st. This is a positive change from Camden Property Trust’s previous quarterly dividend of $1.05. This represents a $4.24 annualized dividend and a dividend yield of 4.2%. Camden Property Trust’s dividend payout ratio (DPR) is currently 119.77%.

Insider Buying and Selling at Camden Property Trust In other news, COO Laurie Baker sold 2,168 shares of the stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $108.40, for a total value of $235,011.20. Following the sale, the chief operating officer directly owned 94,468 shares in the company, valued at approximately $10,240,331.20. This represents a 2.24% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.90% of the company’s stock.

Analysts Set New Price Targets CPT has been the topic of a number of research analyst reports. Stifel Nicolaus set a $118.50 target price on Camden Property Trust in a research report on Friday, February 6th. Weiss Ratings restated a “hold (c)” rating on shares of Camden Property Trust in a research report on Wednesday, January 21st. Royal Bank Of Canada decreased their price objective on Camden Property Trust from $109.00 to $108.00 and set a “sector perform” rating on the stock in a research report on Tuesday, February 10th. Wall Street Zen upgraded Camden Property Trust from a “sell” rating to a “hold” rating in a research report on Saturday, April 4th. Finally, Barclays decreased their price objective on Camden Property Trust from $119.00 to $115.00 and set an “equal weight” rating on the stock in a research report on Friday, March 6th. Five investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Camden Property Trust presently has a consensus rating of “Hold” and a consensus price target of $115.16.

View Our Latest Research Report on Camden Property Trust

Camden Property Trust Profile (Free Report)

Camden Property Trust is a publicly traded real estate investment trust (REIT) specializing in the ownership, development and management of multifamily residential communities across the United States. The company’s core business activities include acquiring land for new construction, overseeing the design and development of garden-style and mid-rise apartment communities, and providing ongoing property management services. Camden’s asset management team focuses on maintaining high occupancy levels, resident satisfaction and operational efficiency through consistent leasing, maintenance and community engagement programs.

Camden’s portfolio encompasses a geographically diversified mix of properties located primarily in high-growth Sun Belt and major metropolitan markets.

See Also Five stocks we like better than Camden Property Trust

Receive News & Ratings for Camden Property Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Camden Property Trust and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEElevation Capital Advisory LLC Purchases New Position in Schwab U.S. Large-Cap Growth ETF $SCHG

NEXT HEADLINE »VanEck Fallen Angel High Yield Bond ETF $ANGL Shares Purchased by Elevation Capital Advisory LLC

Posted by Defense World Staff on Apr 20th, 2026

Davidson Investment Advisors cut its position in shares of Camden Property Trust (NYSE:CPT – Free Report) by 4.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 156,964 shares of the real estate investment trust’s stock after selling 6,954 shares during the period. Davidson Investment Advisors owned approximately 0.15% of Camden Property Trust worth $17,279,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of CPT. Abich Financial Wealth Management LLC purchased a new position in Camden Property Trust during the third quarter worth about $25,000. Quent Capital LLC purchased a new position in Camden Property Trust during the third quarter worth about $29,000. Hantz Financial Services Inc. raised its stake in Camden Property Trust by 524.4% during the third quarter. Hantz Financial Services Inc. now owns 281 shares of the real estate investment trust’s stock worth $30,000 after purchasing an additional 236 shares during the period. CYBER HORNET ETFs LLC purchased a new position in Camden Property Trust during the second quarter worth about $32,000. Finally, Fulcrum Asset Management LLP purchased a new position in Camden Property Trust during the third quarter worth about $32,000. 97.22% of the stock is owned by hedge funds and other institutional investors.

Insider Activity In other news, COO Laurie Baker sold 2,168 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $108.40, for a total value of $235,011.20. Following the sale, the chief operating officer directly owned 94,468 shares of the company’s stock, valued at approximately $10,240,331.20. The trade was a 2.24% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.90% of the company’s stock.

Wall Street Analyst Weigh In A number of equities analysts have commented on CPT shares. Scotiabank reduced their target price on shares of Camden Property Trust from $115.00 to $113.00 and set a “sector perform” rating on the stock in a research note on Wednesday, March 4th. Cantor Fitzgerald lifted their target price on shares of Camden Property Trust from $105.00 to $108.00 and gave the stock a “neutral” rating in a research note on Monday, February 9th. Wall Street Zen raised shares of Camden Property Trust from a “sell” rating to a “hold” rating in a research note on Saturday, April 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Camden Property Trust in a research note on Wednesday, January 21st. Finally, Mizuho lifted their target price on shares of Camden Property Trust from $114.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, January 12th. Five analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $115.16.

View Our Latest Report on CPT

Camden Property Trust Price Performance Camden Property Trust stock opened at $103.52 on Monday. The company’s 50 day simple moving average is $103.64 and its 200-day simple moving average is $104.75. The company has a market capitalization of $10.84 billion, a price-to-earnings ratio of 29.24, a price-to-earnings-growth ratio of 7.04 and a beta of 0.83. Camden Property Trust has a 1 year low of $96.53 and a 1 year high of $121.33. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.14 and a current ratio of 0.14.

Camden Property Trust (NYSE:CPT – Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $1.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.73 by ($0.29). The company had revenue of $396.08 million during the quarter, compared to analysts’ expectations of $393.05 million. Camden Property Trust had a net margin of 24.43% and a return on equity of 8.36%. Camden Property Trust’s revenue was up 1.2% on a year-over-year basis. During the same period last year, the firm posted $1.73 earnings per share. Camden Property Trust has set its Q1 2026 guidance at 1.640-1.680 EPS and its FY 2026 guidance at 6.600-6.900 EPS. As a group, equities research analysts expect that Camden Property Trust will post 6.76 earnings per share for the current year.

Camden Property Trust announced that its Board of Directors has authorized a stock repurchase program on Thursday, February 5th that allows the company to buyback $600.00 million in outstanding shares. This buyback authorization allows the real estate investment trust to purchase up to 5.2% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its shares are undervalued.

Camden Property Trust Increases Dividend The business also recently declared a quarterly dividend, which was paid on Friday, April 17th. Stockholders of record on Tuesday, March 31st were paid a $1.06 dividend. This is a positive change from Camden Property Trust’s previous quarterly dividend of $1.05. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $4.24 dividend on an annualized basis and a dividend yield of 4.1%. Camden Property Trust’s payout ratio is presently 119.77%.

Camden Property Trust Profile (Free Report)

Camden Property Trust is a publicly traded real estate investment trust (REIT) specializing in the ownership, development and management of multifamily residential communities across the United States. The company’s core business activities include acquiring land for new construction, overseeing the design and development of garden-style and mid-rise apartment communities, and providing ongoing property management services. Camden’s asset management team focuses on maintaining high occupancy levels, resident satisfaction and operational efficiency through consistent leasing, maintenance and community engagement programs.

Camden’s portfolio encompasses a geographically diversified mix of properties located primarily in high-growth Sun Belt and major metropolitan markets.

Featured Articles Five stocks we like better than Camden Property Trust

Receive News & Ratings for Camden Property Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Camden Property Trust and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEDavidson Investment Advisors Purchases 16,838 Shares of VanEck Intermediate Muni ETF $ITM

NEXT HEADLINE »Davidson Investment Advisors Has $18.72 Million Stake in Philip Morris International Inc. $PM

HOUSTON--(BUSINESS WIRE)--Camden Property Trust (NYSE:CPT) (the "Company") announced today operating results for the three months ended March 31, 2026. Net Income Attributable to Common Shareholders (“EPS”), Funds from Operations (“FFO”), Core Funds from Operations ("Core FFO"), and Core Adjusted Funds from Operations (“Core AFFO”) for the three months ended March 31, 2026 are detailed below. A reconciliation of EPS to FFO, Core FFO, and Core AFFO is included in the financial tables accompanyin.

Camden (CPT - Free Report) came out with quarterly funds from operations (FFO) of $1.7 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to FFO of $1.72 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an FFO surprise of +2.10%. A quarter ago, it was expected that this real estate investment trust would post FFO of $1.73 per share when it actually produced FFO of $1.76, delivering a surprise of +1.73%.

Over the last four quarters, the company has surpassed consensus FFO estimates four times.

Camden, which belongs to the Zacks REIT and Equity Trust - Residential industry, posted revenues of $388.77 million for the quarter ended March 2026, missing the Zacks Consensus Estimate by 0.48%. This compares to year-ago revenues of $390.57 million. The company has topped consensus revenue estimates just once over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future FFO expectations will mostly depend on management's commentary on the earnings call.

Camden shares have lost about 4.3% since the beginning of the year versus the S&P 500's gain of 4.2%.

What's Next for Camden?While Camden has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's FFO outlook. Not only does this include current consensus FFO expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Camden was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus FFO estimate is $1.66 on $394.76 million in revenues for the coming quarter and $6.74 on $1.58 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust - Residential is currently in the bottom 30% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

American Homes 4 Rent (AMH - Free Report) , another stock in the same industry, has yet to report results for the quarter ended March 2026. The results are expected to be released on May 6.

This real estate company is expected to post quarterly earnings of $0.48 per share in its upcoming report, which represents a year-over-year change of +4.4%. The consensus EPS estimate for the quarter has been revised 0.3% higher over the last 30 days to the current level.

American Homes 4 Rent's revenues are expected to be $467.48 million, up 1.8% from the year-ago quarter.

Key Takeaways CPT's Q1 core FFO was $1.70 per share, beating consensus even as property revenues fell.Camden's same-property NOI slipped 0.7% as expenses rose 1.9%, and blended lease rates hit -1.4%.CPT sold a Texas community, marketed 11 in California, bought 2 after quarter-end. Camden Property Trust (CPT - Free Report) reported first-quarter 2026 core funds from operations (FFO) per share of $1.70, beating the Zacks Consensus Estimate of $1.67 by 1.8%. Core FFO dipped 1.2% year over year from $1.72.

Property revenues were $388.8 million, down 0.5% year over year and modestly below the consensus estimate of $390.7 million (a -0.5% surprise). Same-property occupancy averaged 95.1% for the quarter.

Camden's Same-Property Fundamentals Stay PressuredOperating trends continued to show modest top-line traction and cost pressure. Same-property revenues rose 0.2% year over year, while same-property expenses increased 1.9%, resulting in a 0.7% decline in same-property net operating income (NOI).

Leasing spreads remained soft on new move-ins, while renewals provided partial support. Effective new lease rates were down 5.2% versus expiring leases, and effective renewal rates increased 2.9%, leading to effective blended lease rates of negative 1.4% for the quarter.

CPT's Development and Transaction Activity Remain ActiveLeasing continued at Camden Village District in Raleigh, NC, where construction is complete, and the community was 72% leased as of April 29, 2026. Beyond that, the company had three communities under construction totaling 1,162 apartment homes at an estimated total cost of $492.0 million.

Transaction activity extended beyond development. During the quarter, Camden began marketing 11 operating communities in California for sale and disposed of Camden Valley Park, a 516-home community in Irving, TX, for about $77.0 million. Subsequent to quarter-end, the company acquired Camden Alpharetta (269 homes) and Camden at Lake Nona (288 homes) for a combined $171.3 million.

Camden Details Funding Position, Highlights BuybacksCPT ended the quarter with approximately $881.9 million of liquidity, comprising $40.7 million of cash and cash equivalents and $841.2 million of availability under its unsecured credit facility and commercial paper program. It also had about $176.6 million left to fund within its wholly owned development pipeline.

Leverage increased, with net debt to annualized adjusted EBITDAre at 4.7X compared with 4.1X a year earlier. Interest expense climbed to $37.4 million from $33.8 million in the prior-year quarter. CPT also issued $600 million of senior unsecured notes due 2036 during the quarter and extended the maturity of its $1.2 billion revolving credit facility to March 2030.

Camden continued to lean on share repurchases. During the quarter, it repurchased 2.63 million shares at an average price of $105.88 per share for a total of $278.8 million. Repurchases remained active after quarter-end, with 1.43 million shares bought back at an average price of $100.78 for $144.1 million. So far in the year, the company has repurchased 4.06 million shares for $422.9 million and has $297.8 million remaining under its stock repurchase program.

CPT Updates Guidance, Maintains Same-Property AssumptionsFor second-quarter 2026, Camden guided core FFO per share in the band of $1.65-$1.69. The Zacks Consensus Estimate presently stands at $1.66.

For full-year 2026, core FFO per share guidance remained in the $6.60-$6.90 range. The Zacks Consensus Estimate of $6.74 lies within the guided range.

CPT maintained its same-property growth assumptions. Full-year same-property revenue growth is expected to range from a decline of 0.25% to an increase of 1.75%, while expenses are projected to rise 2.25% to 3.75%. Same-property NOI is forecast between a 2.50% decline and a 1.50% increase.

Camden recorded a $53.0 million litigation settlement-related charge in the quarter after signing a post-quarter term sheet, but said that the settlement payments will not affect its 2026 core FFO or core AFFO. As such, the company noted that its 2026 core FFO guidance excludes roughly 65 cents per share of non-core charges for legal costs and settlements and expensed transaction pursuit costs.

CPT's Zacks RankCamden currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Performance of Other Residential REITsAvalonBay Communities, Inc. (AVB - Free Report) reported first-quarter 2026 core FFO per share of $2.83, beating the Zacks Consensus Estimate of $2.80 by 1.1%. Total revenues came in at $770.3 million, up 3.3% year over year and essentially in line with the consensus mark of $770.6 million.

AvalonBay’s same-store economic occupancy held at 96.1%, underscoring steady demand heading into the peak leasing season. The quarter benefited from incremental development NOI and commercial NOI. However, higher interest expenses undermined the performance of AvalonBay to an extent.

Equity Residential (EQR - Free Report) reported first-quarter 2026 normalized FFO of 99 cents per share, up 4.2% year over year and ahead of the Zacks Consensus Estimate of 95 cents by 4.2%. Rental income grew 2.5% year over year to $779.8 million but came in 0.3% below the consensus mark of $782.6 million.

Equity Residential’s operating fundamentals were supported by steady occupancy and improving coastal-market momentum. Same-store performance remained strong, with revenue growth outpacing prior-quarter momentum and occupancy staying firm. Equity Residential’s management emphasized strength in San Francisco and New York, citing solid demand from higher-earning renters and moderating new supply across its markets.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.

Camden Property Trust (CPT) Q1 2026 Earnings Call Highlights: Strong Revenue and Strategic Financial Moves Amid Market Challenges Camden Property Trust (CPT) surpasses earnings expectations with strategic financial maneuvers and robust market demand, despite facing non-core charges and supply pressures. Summary

Core FFO: $1.70 per share, exceeding guidance midpoint by $0.04.First Quarter Revenue: Higher revenues from operating properties due to lower-than-anticipated bad debt and higher collections on delinquent rent.Property Expense Savings: Contributed $0.02 to outperformance, largely timing related.Non-Core FFO Charges: $58.2 million, primarily from a $53 million class action lawsuit settlement.Same-Store Revenue Guidance: Midpoint reaffirmed at 0.75% for full year 2026.Same-Store Expense Guidance: Midpoint reaffirmed at 3% for full year 2026.Same-Store NOI Guidance: Midpoint remains unchanged at negative 0.5% for full year 2026.Full Year Core FFO Guidance: Midpoint of $6.75 per share.Second Quarter Core FFO Guidance: Expected range of $1.65 to $1.69 per share.Share Repurchases: $423 million at an average price of $104.08 per share during and subsequent to the quarter.Unsecured Bonds Issuance: $600 million of 10-year bonds at an effective rate of 5%.Unsecured Revolving Line of Credit: $1.2 billion recast, extending maturity and lowering pricing by 15 basis points.

Release Date: May 01, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points Camden Property Trust CPT recorded its lowest bad debt level since the onset of COVID-19, attributed to enhanced resident credit screening and increased tax refunds.The company is experiencing strong demand in its markets, particularly in Dallas-Fort Worth, which remains a top destination for headquarter relocations.Camden Property Trust (CPT) has been recognized as a great workplace, ranking 13th on the Fortune Best Place to Work list in America for the 19th consecutive year.The company successfully disposed of a high CapEx community in Dallas, generating a 12% unlevered IRR over a nearly 30-year hold period.Camden Property Trust (CPT) has a strong liquidity position, having recast its $1.2 billion unsecured revolving line of credit and issued $600 million of 10-year unsecured bonds at a 5% rate. Negative Points The company's first quarter outperformance was mainly driven by timing-related items, which may not be sustainable throughout the year.Camden Property Trust (CPT) is facing challenges with new supply pressure, which is expected to moderate as the year progresses.The company recorded $58.2 million of non-core FFO charges, primarily due to a $53 million class action lawsuit settlement.Houston's market performance has been impacted by negative consumer sentiment, despite strong job creation and population growth.Camden Property Trust (CPT) anticipates a sequential decline in core FFO per share for the second quarter, driven by seasonal expenses and timing of merit increases. Q & A Highlights Q: Could you talk about the expected ramp in lease spreads for the rest of the year and any early signs of improvement?
A: Ric Campo, Executive Chairman, explained that April occupancy was around 95.4%, up from 95.1% in the first quarter. Blended rates in April improved by about 100 basis points compared to the first quarter. The company anticipates a strong third quarter as new supply is absorbed, leading to a better-than-usual fourth quarter. Markets like Atlanta, Dallas, Orlando, Nashville, Raleigh, and Southeast Florida are showing positive signs.

Q: Can you discuss the trend in concessions and expectations for the rest of the year?
A: Alex Jessett, CEO, stated that Camden does not offer concessions, but they have observed a significant reduction in concessions across most markets due to decreased new supply. The company is seeing fewer developers offering concessions as they no longer need to rapidly fill new properties.

Q: What are your expectations for renewal lease rates, and how do they compare to previous quarters?
A: Laurie Baker, COO, noted that renewal offers for May, June, and July are in the mid-3% range. The company is seeing less price sensitivity and expects to achieve slightly higher increases as they enter peak leasing season. Resident retention remains high, which supports their pricing strategy.

Q: How does Camden view the potential benefits of scale and data in the context of industry consolidation?
A: Alex Jessett, CEO, emphasized that bigger is not necessarily better. Camden believes it has sufficient data to make informed decisions and does not see significant benefits from being larger. The company focuses on using its existing data effectively to drive performance.

Q: Can you provide insights into the acquisition environment and cap rates in Sunbelt markets?
A: An unidentified company representative mentioned that transaction volumes are below pre-COVID levels but are similar to 2025. Cap rates for newer, well-located properties in the Sunbelt are stable, ranging from 4.5% to 5%. The company is actively evaluating opportunities to redeploy proceeds from its California sale.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

HOUSTON--(BUSINESS WIRE)--Camden Property Trust (NYSE:CPT) (the “Company”) announced today it will participate in the Nareit REITweek 2026 Investor Conference on Tuesday, June 2 and Wednesday, June 3, 2026. The Company also provided an update on second quarter 2026 operating trends, indicating that performance to date is in line with guidance and expectations provided in conjunction with its first quarter 2026 earnings release. A copy of Camden's most recent Investor Presentation can be found i.

Key Takeaways Camden cited one of its strongest first-quarter apartment absorption periods since 2016.CPT expects falling new supply across most markets and 2026 same-property expense growth of 2.25-3.75%.Camden plans $1.0-$1.2B of acquisitions and $1.6-$2.0B of dispositions in 2026. Shares of Camden Property Trust (CPT - Free Report) have risen 9.1% over the past six months against the industry’s 0.2% decline.

Camden benefits from durable renter demand in large Sunbelt markets where migration and steep homeownership costs support apartment needs. Operations remain steady, helped by a diversified urban/suburban mix and continued investment in technology and process efficiency. Capital recycling is advancing, with proceeds expected to be redeployed via exchanges and share repurchases.

Analysts seem bullish about this Zacks Rank #3 (Hold) company. The Zacks Consensus Estimate for CPT’s 2026 funds from operations (FFO) per share has moved 2 cents northward over the past month to $6.76.

Image Source: Zacks Investment Research

Factors Behind CPT’s Stock Price RiseCamden targets metros with in-migration and jobs in higher-wage sectors, which supports steady leasing even when consumer sentiment is mixed. Management noted first-quarter apartment absorption was among the best since 2016 and expects new supply to keep falling across most of its markets.

Camden maintains a broad footprint across 15 major markets and a mix of 41% urban and 59% suburban communities. This blend helps balance exposure to downtown demand shifts and suburban affordability needs. It also allows Camden to optimize pricing by submarket and limit volatility when certain metros face heavier deliveries or slower job growth.

Camden is investing in technology and AI to streamline leasing, reduce repetitive tasks and improve service response times. Management expects expense growth of 2.25% to 3.75% in 2026 on a same-property basis, suggesting these efforts can help offset inflation.

Camden continues to rotate capital by selling older, higher-capex assets and redeploying into core markets. In the first quarter of 2026, it sold a community in Irving, TX, for $77 million and recognized a gain of $67.9 million. Management continues to assume sale proceeds will be reinvested into high-demand Sunbelt markets and share repurchases. For 2026, Camden expects acquisitions of $1-$1.2 billion and dispositions of $1.6-$2 billion, keeping capital recycling a central earnings and NAV driver.

Camden has a healthy balance sheet with ample liquidity, positioning it well to capitalize on long-term growth opportunities. Liquidity increased to about $881.9 million as of March 31, 2026, consisting of cash and availability under the unsecured credit facility and commercial paper program. Credit metrics remain supported by interest expense coverage of 6.0X in first-quarter 2026 and an unencumbered real estate assets-to-unsecured debt ratio of 3.2, which helps fund development and acquisition activity without forcing near-term equity issuance.

Risks Likely to Affect CPT’s Positive TrendAn elevated supply of apartment units in some markets and portfolio concentration in certain regions raise concerns for Camden. High interest expenses add to the company’s woes.

Stocks to ConsiderSome better-ranked stocks from the residential REIT sector are Centerspace (CSR - Free Report) and Invitation Home (INVH - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for CSR’s 2026 FFO per share is pegged at $4.85, moving marginally northward over the past month.

The consensus estimate for INVH’s full-year FFO per share is pinned at $1.95, being revised upward by a cent over the past month.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

The proposed transactions may contain terms that could limit superior competing offers.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)'s sale to Biogen Inc. for $41.00 per share in cash and a nontransferable contingent value right for the right to receive two payments of $2.00 per share each, contingent on certain annual global net sales thresholds being met for SYFOVRE. If you are an Apellis shareholder, click here to learn more about your legal rights and options.

Centessa Pharmaceuticals plc (NASDAQ: CNTA)'s sale to Eli Lilly and Company for $38.00 in cash per share plus one non-transferrable contingent value right entitling the holder to receive up to an aggregate of $9.00 subject to the achievement of certain milestones. If you are a Centessa shareholder, click here to learn more about your legal rights and options.

Allbirds, Inc.'s (NASDAQ: BIRD)'s sale of its intellectual property and certain other assets to American Exchange Group for $39 million. If you are an Allbirds shareholder, click here to learn more about your legal rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- LLP is investigating Centessa (NASDAQ: CNTA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Lilly.

Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.

In the transaction, Centessa stockholders will receive $38.00 per share in cash plus contingent value rights worth up to $9.00 per share. The contingent value rights entitle holders to receive up to three milestone payments: $2.00 upon U.S. FDA approval for narcolepsy type 2 treatment, $5.00 for idiopathic hypersomnia approval, and $2.00 for any indication approval before January 1, 2030. All approvals must occur within five years of transaction closing.

Centessa insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for Centessa by imposing a significant penalty if Centessa accepts a competing bid. We are investigating the conduct of the Centessa board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

SOURCE Ademi LLP

Also from this source

Centessa Pharmaceuticals PLC (NASDAQ:CNTA) shares are surging today, last seen 44.4% higher to trade at $39.90 on news that Eli Lilly (LLY) will acquire the company for $6.3 billion. The move is part of the former's plans to diversify its metabolic portfolio with sleep disorder treatments.

Analysts chimed in on the update, with Needham and B. Riley downgrading CNTA to "hold" and "neutral," respectively, from "buy." Piper Sandler cut its rating to "neutral" from "overweight." Analysts were bullish coming into today, with 16 of the 17 in coverage sporting "buy" or better ratings.

Options traders are targeting CNTA, too, with 3,467 calls and 2,687 puts traded so far -- 11 times the volume typically seen at this point. Most active is the April 30 call, followed by the December 22.50 puts.

CNTA is headed for its best day on record and earlier scored an all-time high of $40.26. The shares are staging a bounce off the rising 40-day moving average, and now sport a more than 203% nine-month lead.

Shares of Centessa Pharmaceuticals (CNTA 0.14%) surged on Tuesday after the drugmaker struck a deal to be acquired by Eli Lilly (LLY 0.51%) for as much as $7.8 billion.

Image source: Getty Images.

An enticing offer for Centessa's investors Under the terms of the deal, Lilly would purchase Centessa for $38 per share in cash. That's a premium of nearly 38% to the healthcare stock's closing price on Monday.

Centessa's shareholders would also receive a non-transferrable contingent value right, which could be valued at up to $9 per share if the pharmaceutical company's investigational drugs achieve certain regulatory milestones.

The transaction is projected to close in the third quarter, subject to shareholder and regulatory approval.

Today's Change

(

-0.14

%) $

-0.06

Current Price

$

39.70

Advancing neuroscience Centessa is developing a novel class of drugs, known as orexin receptor 2 (OX2R) agonists, to treat daytime sleepiness and other neurological conditions. Its most promising experimental drug, cleminorexton, showed best-in-class potential in Phase 2 clinical studies for severe sleep disorders, including narcolepsy and idiopathic hypersomnia.

"Orexin receptor biology represents one of the most compelling mechanistic opportunities in neuroscience as a direct intervention on the master switch of the sleep-wake cycle," Lilly executive Carole Ho said. "Centessa has assembled a portfolio with the breadth and depth to improve wakefulness across a broad array of indications."

Blockbuster potential Lilly is wisely using the windfall from its highly successful GLP-1 drugs Mounjaro and Zepbound to diversify its development pipeline. Centessa's experimental therapies could become top sellers in a potential $20 billion market for treatments for severe sleep conditions, according to investment bank Oppenheimer.

Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Centessa Pharmaceuticals Plc. The Motley Fool has a disclosure policy.

© mezzotint / Shutterstock.com

Pre-Market Stock Futures: Futures are trading higher after an explosive rally on Tuesday, sparked by the President’s comments that he wants to end the war soon. While this is hardly the final straw for the war, it appears that President Trump, who is finally getting some support from NATO members and Persian Gulf allies in the fight against Iran and its paid proxies, may be making some progress. Add in the fact that Iran’s infrastructure and weaponry have been devastated, and many of the military and Revolutionary Guard leaders have been killed. Toss in the massive short interest, and it all adds up to Tuesday’s huge rally, with the Nasdaq as the big winner, closing up a stunning 3.83% at 21,590, and the small-cap Russell 2000 not far behind, finishing the session at 2,496, up 3.41%. The S&P 500 closed Tuesday at 6,528, up 2.91%, and the Dow Jones Industrial finished the clean sweep of winners, closing at 46,341, up 2.49%.

Treasury Bonds: Yields were lower across the curve, except at the very short T-bills and the long end, as buyers returned, as they did on Monday. Some of the same reasons we have cited recently for bond prices rising (and yields falling) were again driven by safe-haven demand amid intensified Middle East conflict. Investors shifted from fears of inflation to concerns about slower global growth, prompting a “bull steepening” of the yield curve and a rebound after a month of heavy selling.

Oil and Gas: Prices were mixed across the energy complex, which experienced severe intraday volatility, initially dropping on reports of a potential de-escalation in Iran but remaining supported by lingering anxieties over supply disruptions, particularly after a tanker was hit near Dubai. Toss in futures contract expirations, and the stage was set for a crazy end to the quarter. Brent Crude closed up 4.94% at $118.30, while West Texas Intermediate closed down at $101.50, down 1.33%. Natural Gas finished the day at $2.84, dowm 0.10%. 

Gold: The precious metals joined in on the rally as gold, which has traded in a tight range for the better part of the first quarter, had an impressive day, closing trading up a whopping 3.49% at $4,667, while Silver really had some momentum buying and was last seen on Tuesday at $75, up a strong 7.18%. Wall Street analysts attributed the big moves higher to the recent decline to market overreaction, as investors moved to buy the dip. This rebound suggests a resilient bullish sentiment, even as the market grapples with rising oil prices, inflationary pressure, and weakening consumer confidence.

Crypto: The cryptocurrency market endured a turbulent session marked by sharp price swings but demonstrated solid resilience, holding firm at key support levels amid heightened geopolitical tensions. Developments heavily influenced risk sentiment across the broader crypto space, as traders responded swiftly to shifting headlines. Bitcoin led the volatility, surging to an intraday high of $68,300 in early trading after reports emerged of potential peace negotiations between Iran and Israel briefly lifted market optimism. However, the rally proved short-lived, with the crypto giant retracing to a consolidation range of $67,000–$67,800 as uncertainty resurfaced and profit-taking set in. The speed of the reversal underscored how sensitive the market remains to geopolitical developments, with algorithmic trading and leveraged positions amplifying the intraday swings. At 8 AM EDT, Bitcoin was trading at $68,680 while Ethereum was quoted at $2,135. 

24/7 Wall St. reviews dozens of analyst research reports daily to identify new investment ideas for both investors and traders. Some of these daily analyst calls cover stocks to buy. Other calls cover stocks to sell or avoid. Remember that no single analyst call should ever be used as a basis to buy or sell a stock. 

Here are some of the top Wall Street analyst upgrades, downgrades, and initiations seen on Wednesday, April 1, 2026.  

Upgrades: Formula One Group (NASDAQ: FWONK | FWONK Price Prediction) was raised to Buy from Neutral at Bank of America, which has a $105 price target for the shares. Rivian Automotive Inc. (NASDAQ: RIVN) was upgraded to Neutral from Underperform at DA Davidson, with a $14 target price. United Health Group Inc. (NYSE: UNH) was upgraded to Outperform from Market Perform at Raymond James, which posted a $330 target price objective. Walt Disney Company (NYSE: DIS) was raised to Outperform from Market Perform at Raymond James, which has a $115 target for the entertainment giant. Wells Fargo & Company (NYSE: WFC) was upgraded to Buy from Hold at HSBC, with a $94 target price. Downgrades:
Apellis Pharmaceutical Inc. (NASDAQ: APLS) was downgraded to Hold from Buy at Stifel with a $41 target price as Biogen is acquiring the company. Centessa Pharmaceuticals Inc. (NASDAQ: CNTA) was downgraded to Market Perform from Outperform at Leerink, with a $40 target, as Eli Lilly is acquiring the company. First Citizens Bancshares Inc. (NASDAQ: FCNCA) was cut to Neutral from Overweight at JPMorgan, which dropped the target price for the shares to $2,200 from $2,450. Nike Inc. (NYSE: NKE) was downgraded to Neutral from Overweight at JPMorgan, which slashed the target price for the sports apparel and shoe giant to $52 from $86. PPG Industries Inc. (NYSE: PPG) was downgraded to Neutral from Buy at Citigroup, which trimmed the target price for the stock to $113 from $132. Initiations: Boeing Company (NYSE: BA) was initiated with an Overweight rating at Wells Fargo, which has a $250 target price for the aerospace giant.
Datadog Inc. (NASDAQ: DDOG) was started with a Buy rating at Benchmark, with a $150 target price. Northrop Grumman Corp. (NYSE: NOC) was started with an Overweight rating at Wells Fargo, with an $800 target price objective. Rocket Lab Corp. (NASDAQ: RKLB) was initiated with an Equal Weight rating at Wells Fargo, with a $60 target price. ServiceNow Inc. (NYSE: NOW) was initiated with a Buy rating at Benchmark with a $125 target price.

, /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Centessa Pharmaceuticals plc (NASDAQ: CNTA) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, Centessa shareholders are expected to receive $38.00 per share in cash and one non-transferable contingent value right entitling the holder to receive up to an aggregate of $9.00 subject to the achievement of certain milestones. Is it a fair deal?

Click here for more info https://monteverdelaw.com/case/centessa-pharmaceuticals-plc/. It is free and there is no cost or obligation to you.

NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask:

Do you file class actions and go to Court? When was the last time you recovered money for shareholders? What cases did you recover money in and how much? About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

No one is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE Monteverde & Associates PC